Idexx Laboratories (IDXX) Deferred Taxes (2009 - 2026)

Idexx Laboratories (IDXX) has reported Deferred Taxes for 18 consecutive years, with $13.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Deferred Taxes rose 251.82% year-over-year to $13.9 million; the TTM figure through Mar 2026 stood at $141.1 million (up 898.56% YoY), while the FY2025 annual figure was $131.2 million, up 642.3% from the prior year.
• Deferred Taxes came in at $13.9 million for Q1 2026 at Idexx Laboratories, down from $31.5 million in the prior quarter.
• The five-year high for Deferred Taxes was $93.2 million in Q3 2025, with the low at -$33.6 million in Q4 2023.
• Average Deferred Taxes over 5 years is $2.2 million, with a median of -$2.6 million recorded in 2024.
• Across the five-year window, Deferred Taxes plunged 9186.81% in 2022 and surged 1461.48% in 2025, its largest moves.
• Year by year, Deferred Taxes stood at $1.8 million in 2022, then tumbled by 1938.74% to -$33.6 million in 2023, then surged by 113.93% to $4.7 million in 2024, then surged by 574.27% to $31.5 million in 2025, then sank by 55.95% to $13.9 million in 2026.
• According to Business Quant data, Deferred Taxes over the past three periods registered $13.9 million, $31.5 million, and $93.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.